Showing results (171-180 of 305) with videos related to
Sort By:
Pageof 31
European Heart Journal. Case Reports|January 26, 2022
Immune checkpoint inhibitor-related myocarditis: an illustrative case series of applying the updated Cardiovascular Magnetic Resonance Lake Louise CriteriaBernd J Wintersperger, Oscar Calvillo-Argüelles, Stephanie Lheureux, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2019
FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter studyMarie Plante, Nienke van Trommel, Stephanie Lheureux, et al.Apoptosis : an International Journal on Programmed Cell Death|January 25, 2013
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axisKarin Simonin, Monique N'Diaye, Stéphanie Lheureux, et al.Gynecologic Oncology|October 18, 2015
Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directionsS Lheureux, K Karakasis, P Harter, et al.Gynecologic Oncology|March 29, 2020
Supported self-management as a model for end-of-life care in the setting of malignant bowel obstruction: A qualitative studyMaria C Cusimano, Katrina Sajewycz, Michelle Nelson, et al.Journal of Virology|April 18, 2008
A single Banana streak virus integration event in the banana genome as the origin of infectious endogenous pararetrovirusPhilippe Gayral, Juan-Carlos Noa-Carrazana, Magali Lescot, et al.Materials (Basel, Switzerland)|December 23, 2022
Optimization of Processing Steps for Superior Functional Properties of (Ba, Ca)(Zr, Ti)O3 CeramicsCristina Elena Ciomaga, Lavinia P Curecheriu, Vlad Alexandru Lukacs, et al.Cold Spring Harbor Molecular Case Studies|December 15, 2019
Heterogeneous alteration of the ERBB3-MYC axis associated with MEK inhibitor resistance in a KRAS-mutated low-grade serous ovarian cancer patientIlaria Colombo, Swati Garg, Arnavaz Danesh, et al.Gynecologic Oncology|April 22, 2015
A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: a trial of the Princess Margaret, Chicago and California Phase II ConsortiaH Hirte, S Lheureux, G F Fleming, et al.Annals of Neurology|November 1, 1985
Dopaminergic and cholinergic lesions in progressive supranuclear palsyM Ruberg, F Javoy-Agid, E Hirsch, et al.Pageof 31